Aromatase inhibitors in breast cancer: current and evolving roles.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12109640.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aromatase inhibitors are established first-line drugs for treating metastatic breast cancer in postmenopausal women, and are gaining acceptance as adjuvant treatment as well.